Royce & Associates’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-15,365
| Closed | -$334K | – | 872 |
|
|
2024
Q2 | $334K | Buy |
15,365
+4,240
| +38% | +$92.3K | ﹤0.01% | 818 |
|
|
2024
Q1 | $246K | Sell |
11,125
-20,517
| -65% | -$454K | ﹤0.01% | 821 |
|
|
2023
Q4 | $683K | Buy |
31,642
+8,833
| +39% | +$191K | 0.01% | 768 |
|
|
2023
Q3 | $385K | Buy |
+22,809
| New | +$385K | ﹤0.01% | 833 |
|
|
2021
Q1 | – | Sell |
-35,000
| Closed | -$2.35M | – | 1021 |
|
|
2020
Q4 | $2.35M | Sell |
35,000
-481
| -1% | -$32.3K | 0.02% | 693 |
|
|
2020
Q3 | $1.83M | Buy |
35,481
+6,481
| +22% | +$333K | 0.02% | 695 |
|
|
2020
Q2 | $1.09M | Buy |
+29,000
| New | +$1.09M | 0.01% | 761 |
|